No. | COMPOUND | METHOD | MATRIX | LLOQ |
01 | Aldosterone |
LC/MS/MS |
Human Urine |
0.1 ng/mL |
02 |
Aldosterone |
LC/MS/MS |
K2EDTA Human Plasma |
10 pg/mL |
05 |
Angiotensin I |
LC/MS/MS |
K2EDTA Human Plasma |
0.14 ng/mL |
06 |
Angiotensin II |
Immunoassay |
K2EDTA Human Plasma |
3.9 pg/mL |
07 |
Arachidonic Acid, HETE, LTB4 |
LC/MS/MS |
Cell Culture Media |
0.025 µM |
08 |
Ascorbic Acid |
LC/MS/MS |
Human Tissue and Lavage Fluid |
20 ng/mL |
41 |
Glutarate, 2-Hydroxy |
LC/MS/MS |
Cell Culture Media |
2.5 ng/mL |
44 |
Ketoprofen |
LC/MS/MS |
K2EDTA Human Plasma |
10 ng/mL |
45 |
Levothyroxine (Free T4) |
Immunoassay |
Human Serum |
0.3 ng/mL |
46 |
Levothyroxine (Total T4) |
LC/MS/MS |
Human Serum |
10 ng/mL |
47 |
Liothyronine (Free T3) |
Immunoassay |
Human Serum |
1 pg/mL |
48 |
Liothyronine (Total T3) |
LC/MS/MS |
Human Serum |
0.1 ng/mL |
51 |
Lysophosphatidyl acid |
LC/MS/MS |
K2EDTA Mouse Plasma |
10 nM |
52 |
Lysophosphatidylcholine |
LC/MS/MS |
K2EDTA Mouse Plasma |
10 nM |
53 |
Malonyl Coenzyme A |
LC/MS/MS |
Tissue |
10 ng/g |
54 |
Melatonin |
LC/MS/MS |
K2EDTA Human Plasma |
1 pg/mL |
60 |
Plasma Renin Activity |
LC/MS/MS |
K2EDTA Human Plasma |
0.05 ng/mL/hr |
62 |
Potassium |
ICP-MS |
Human Urine |
20 µg/mL |
70 |
Thyrotropin Stimulating Hormone (TSH) |
Immunoassay |
Human Serum |
0.2 µIU/mL |
72 | Urea |
LC/MS/MS |
KOx/NaF Human Plasma |
100 µg/mL |
73 |
Urea |
LC/MS/MS |
Human Bronchoalveolar Lavage |
0.2 µg/mL |
74 |
Uric Acid |
LC/MS/MS |
Human Tissue and Lavage Fluid |
5 ng/mL |
82 |
Vitamin D2, 1, 25-Dihydroxy |
LC/MS/MS |
Human Serum |
10 pg/mL |
83 |
Vitamin D2, 25-Hydroxy |
LC/MS/MS |
Human Serum |
5 ng/mL |
84 |
Vitamin D3 |
LC/MS/MS |
K2EDTA Human Plasma |
0.5 ng/mL |
85 |
Vitamin D3, 1, 25-Dihydroxy |
LC/MS/MS |
Human Serum |
10 pg/mL |
86 |
Vitamin D3, 25-Hydroxy |
LC/MS/MS |
Human Serum |
5 ng/mL |
87 |
Vitamin D3, 25-Hydroxy |
LC/MS/MS |
K2EDTA Human Plasma |
1 ng/mL |